Answers are grounded in this paper and cite their sources.
The era of precision medicine has arrived. A large share of new pharmaceuticals are tested and approved on the basis of biomarkers. Pharmacogenetics—the tailoring of drugs to patients based on 1 or more biomarkers—is used in conditions as diverse as HIV and thromboembolism.
No takes yet. Share an insight, caveat, or question.
David Cutler (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: